Daniel graduated from the Moscow Institute of Physics and Technology, Molecular and Biological Physics department. He worked in the Institute of Physiological Active Compound RAS for almost seven years in the Computer-Aided Molecular Design department. Daniel’s research field was quantitative and classification models for the aqueous solubility of organic compounds, blood-brain barrier permeability, and intestinal absorption. Then, he joined the BIOCAD biotechnological company and became a part of the cancer and autoimmune program team. He and his colleagues invented a few potential compounds that are currently being studied in preclinical research. In September 2022, he joined the Laboratory of Immunology and Tissue Engineering of L.A. Orbeli Institute of Physiology. His research interests are Molecular and Cell Biology, Cancer Biology, and Autoimmune Diseases.